Skip to main content
37°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Effector Therapeutics Inc
(NQ:
EFTR
)
1.890
+0.080 (+4.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Effector Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Is eFFECTOR Therapeutics (EFTR) Stock Up 75% Today?
May 26, 2023
EFFECTOR Therapeutics (EFTR) stock is taking off on Friday after the company reported positive data from a Phase 2 clinical trial.
Via
InvestorPlace
Why eFFECTOR Therapeutics Shares Trading Higher Today
May 26, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 26, 2023
It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!
Via
InvestorPlace
eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting
May 25, 2023
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
Recap: eFFECTOR Therapeutics Q1 Earnings
May 09, 2023
Via
Benzinga
eFFECTOR Therapeutics Collaborates With Stanford Medicine Mid-Stage Breast Cancer Study
April 11, 2023
Via
Benzinga
Looking Into eFFECTOR Therapeutics's Return On Capital Employed
March 13, 2023
Via
Benzinga
3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
May 11, 2023
These 3 penny stocks have 10X potential over the next twelve months, providing the right risk/reward bet for certain investors.
Via
InvestorPlace
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference
May 08, 2023
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
Why Hitek Global Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
April 28, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 27, 2023
Via
Benzinga
eFFECTOR to Present Updated Clinical Data from Phase 2 Expansion Cohorts for Zotatifin in Patients with ER+ Metastatic Breast Cancer at ASCO 2023 Annual Meeting
April 26, 2023
eFFECTOR to host conference call following ASCO presentation
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 11, 2023
Via
Benzinga
eFFECTOR Therapeutics to Collaborate with Stanford Medicine on Investigator-Initiated Randomized Phase 2 Study in Patients with ER+ Breast Cancer
April 11, 2023
The Company’s eIF4A inhibitor, zotatifin, will be tested in specific genomically-defined subgroups, including standard risk patients as well as high-risk patients carrying specific markers predictive...
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.
Via
Benzinga
eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
March 28, 2023
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 08, 2023
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 28, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 28, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 22, 2023
Via
Benzinga
Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
February 22, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 21, 2023
Via
Benzinga
S&P 500 Down 2%; Mobilicom Shares Spike Higher
February 21, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 2% on Tuesday. The Dow traded down 2.06% to 33,129.04 while the NASDAQ fell 2.39% to 11,506.10. The S&P...
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
February 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 500 points on Tuesday. The Dow traded down 1.61% to 33,280.92 while the NASDAQ fell 2.05% to 11,545.79. The S&P...
Via
Benzinga
eFFECTOR Therapeutics Shares Fall After Data From COVID-19 Treatment Trial
February 21, 2023
Via
Benzinga
eFFECTOR Therapeutics Announces Positive Top-Line Results from Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID
February 21, 2023
Results presented at 30th Conference on Retroviruses and Opportunistic Infections (CROI)
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
eFFECTOR Therapeutics to Present at 2023 BIO CEO & Investor Conference
January 30, 2023
From
eFFECTOR Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.